Why Moderna Stock Just Went Up
In this episode of MarketFoolery, host Chris Hill chats with analyst Emily Flippen about the latest quarterly results and news from Wall Street. They talk about why Moderna (NASDAQ: MRNA) is facing backlash from some quarters around its COVID-related announcements. Another healthcare provider posted robust earnings, beating market expectations. Also, Emily shares a stock to keep on your watch list.
To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center. To get started investing, check out our quick-start guide to investing in stocks. A full transcript follows the video.
Source Fool.com
